The total global stem cell therapy market was valued at around 755 million U.S. dollars in 2018 , and it is projected to reach around 11 billion dollars by 2029 . Stem cell therapies are mostly distributed into two types : autologous treatment ( treatment with patient 's own stem cells ) and allogenic treatment ( treatment with donor 's stem cells ) . The market share of autologous treatments is expected to drop from 56 to some 36 percent from 2018 to 2029 .
